Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer

Low SMD is associated with poorer survival in advanced NSCLC. Further research is warranted to establish whether muscle measures should be integrated into routine practice to improve prognostic accuracy.